GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,401,000 | -36.2% | 284,891 | -70.0% | 0.08% | -34.5% |
| Q2 2022 | $30,388,000 | +36.5% | 951,111 | +47.9% | 0.12% | +50.6% |
| Q1 2022 | $22,270,000 | +89.8% | 642,904 | +60.4% | 0.08% | +97.4% |
| Q4 2021 | $11,731,000 | +46.6% | 400,787 | +27.6% | 0.04% | +30.0% |
| Q3 2021 | $8,003,000 | -61.2% | 314,073 | -46.7% | 0.03% | -59.5% |
| Q2 2021 | $20,624,000 | -5.7% | 588,921 | +9.7% | 0.07% | -17.8% |
| Q1 2021 | $21,875,000 | +95.6% | 536,822 | +107.9% | 0.09% | +73.1% |
| Q4 2020 | $11,181,000 | -32.6% | 258,155 | -14.2% | 0.05% | -44.7% |
| Q3 2020 | $16,581,000 | +12.2% | 300,713 | +28.5% | 0.09% | -6.0% |
| Q2 2020 | $14,774,000 | – | 234,018 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |